SERA PROGNOSTICS (SERA) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$2.04
+1.0% on the day
-36.3% over 12 months
52-week range $1.59 – $3.75
Share price and insider trades
SERA closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$643K
Insiders buying0
Insiders selling10
SERA PROGNOSTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 10 sold $643K of SERA stock on the open market.
Get emailed when insiders cluster-buy stocks like SERA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
SERA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $63K | 5 |
| Q2 2026 | — | 0 | $91K | 8 |
| Q1 2026 | — | 0 | $110K | 16 |
| Q4 2025 | — | 0 | $386K | 24 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.4×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 SERA PROGNOSTICS, INC. insiders reported open-market purchases totaling $0, while 10 insiders reported sales totaling $643K. 10 of 53 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 11SEC | Zhenya LindgardtCEO | Sell | 7,022837,848 held (−1%) | $2.00 | $14K | +2.0% | — |
| Sep 11SEC | Benjamin JacksonGeneral Counsel | Sell | 2,190159,566 held (−1%) | $2.00 | $4K | +2.0% | — |
| Sep 11SEC | Dyaarl Lee Anderson Jr.Chief Commercial Officer | Sell | 1,80076,198 held (−2%) | $2.00 | $4K | +2.0% | — |
| Sep 11SEC | Tiffany Eul Davis InglisChief Medical Officer | Sell | 48691,589 held (−1%) | $2.00 | $972 | +2.0% | — |
| Sep 9SEC | Zhenya LindgardtCEO | Sell | 20,139844,870 held (−2%) | $2.00 | $40K | +2.0% | — |
| Jun 15SEC | Zhenya LindgardtCEO | Sell | 6,990865,009 held (−1%) | $2.01 | $14K | +1.5% | — |
| Jun 15SEC | Dyaarl Lee Anderson Jr.Chief Commercial Officer | Sell | 4,73977,998 held (−6%) | $2.01 | $10K | +1.5% | — |
| Jun 15SEC | Benjamin JacksonGeneral Counsel | Sell | 2,179161,756 held (−1%) | $2.01 | $4K | +1.5% | — |
| Jun 15SEC | Austin AertsCFO | Sell | 2,037301,190 held (−1%) | $2.01 | $4K | +1.5% | — |
| Jun 15SEC | Tiffany Eul Davis InglisChief Medical Officer | Sell | 36292,075 held (−0%) | $2.01 | $728 | +1.5% | — |
| Jun 10SEC | Zhenya LindgardtCEO | Sell | 20,755871,999 held (−2%) | $2.08 | $43K | -1.9% | — |
| Jun 10SEC | Austin AertsCFO | Sell | 5,440303,227 held (−2%) | $2.08 | $11K | -1.9% | — |
| Jun 9SEC | Sandra Aj LawrenceDirector | Sell Plan | 1,56016,473 held (−9%) | $2.15 | $3K | -5.1% | — |
| Mar 12SEC | Zhenya LindgardtCEO | Sell | 22,639741,287 held (−3%) | $1.90 | $43K | +7.4% | — |
| Mar 12SEC | Austin AertsCFO | Sell | 6,069265,471 held (−2%) | $1.90 | $12K | +7.4% | — |
| Mar 12SEC | Zhenya LindgardtCEO | Sell | 2,973738,314 held (−0%) | $2.04 | $6K | +0.0% | — |
| Mar 12SEC | John J. BonifaceChief Scientific Officer | Sell | 1,517145,842 held (−1%) | $2.04 | $3K | +0.0% | — |
| Mar 12SEC | Paul KearneyChief Data Officer | Sell | 1,396163,961 held (−1%) | $2.04 | $3K | +0.0% | — |
| Mar 12SEC | Benjamin JacksonGeneral Counsel | Sell | 1,027114,720 held (−1%) | $2.04 | $2K | +0.0% | — |
| Mar 12SEC | Austin AertsCFO | Sell | 1,019264,452 held (−0%) | $2.04 | $2K | +0.0% | — |
| Mar 12SEC | Robert Gardner HarrisonChief Information Officer | Sell | 71676,712 held (−1%) | $2.04 | $1K | +0.0% | — |
| Mar 10SEC | Robert Gardner HarrisonChief Information Officer | Sell | 3,36077,428 held (−4%) | $1.96 | $7K | +4.1% | — |
| Mar 10SEC | Benjamin JacksonGeneral Counsel | Sell | 3,119115,747 held (−3%) | $1.96 | $6K | +4.1% | — |
| Mar 10SEC | John J. BonifaceChief Scientific Officer | Sell | 3,038147,359 held (−2%) | $1.96 | $6K | +4.1% | — |
| Mar 10SEC | Paul KearneyChief Data Officer | Sell | 2,026165,357 held (−1%) | $1.96 | $4K | +4.1% | — |
| Mar 10SEC | Austin AertsCFO | Sell | 674271,540 held (−0%) | $1.96 | $1K | +4.1% | — |
| Mar 6SEC | Sandra Aj LawrenceDirector | Sell Plan | 1,56018,033 held (−8%) | $1.95 | $3K | +4.6% | — |
| Feb 24SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00080,788 held (−2%) | $2.34 | $5K | -12.8% | — |
| Jan 27SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00082,788 held (−2%) | $2.97 | $6K | -31.3% | — |
| Dec 30SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00084,788 held (−2%) | $3.00 | $6K | -32.0% | — |
| Dec 11SEC | Zhenya LindgardtCEO | Sell | 4,155763,926 held (−1%) | $3.31 | $14K | -38.4% | — |
| Dec 11SEC | John J. BonifaceChief Scientific Officer | Sell | 1,332150,397 held (−1%) | $3.31 | $4K | -38.4% | — |
| Dec 11SEC | Paul KearneyChief Data Officer | Sell | 1,213167,383 held (−1%) | $3.31 | $4K | -38.4% | — |
| Dec 11SEC | Benjamin JacksonGeneral Counsel | Sell | 892118,866 held (−1%) | $3.31 | $3K | -38.4% | — |
| Dec 11SEC | Austin AertsCFO | Sell | 873272,214 held (−0%) | $3.31 | $3K | -38.4% | — |
| Dec 11SEC | Robert Gardner HarrisonChief Information Officer | Sell | 61686,788 held (−1%) | $3.31 | $2K | -38.4% | — |
| Dec 10SEC | Zhenya LindgardtCEO | Sell | 28,215768,081 held (−4%) | $3.04 | $86K | -32.9% | — |
| Dec 10SEC | Austin AertsCFO | Sell | 5,232273,087 held (−2%) | $3.04 | $16K | -32.9% | — |
| Dec 8SEC | Sandra Aj LawrenceDirector | Sell Plan | 1,56019,593 held (−7%) | $3.05 | $5K | -33.1% | — |
| Dec 5SEC | Mansoor Raza MirzaDirector | Sell | 29257,740 held (−1%) | $3.05 | $891 | -33.1% | — |
| Dec 3SEC | Paul KearneyChief Data Officer | Sell | 32,203168,596 held (−16%) | $2.94 | $95K | -30.6% | — |
| Dec 3SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00087,404 held (−2%) | $2.93 | $6K | -30.4% | — |
| Nov 26SEC | Paul KearneyChief Data Officer | Sell Plan | 1,986168,596 held (−1%) | $3.51 | $7K | -41.9% | — |
| Nov 12SEC | Zhenya LindgardtCEO | Sell | 11,594796,296 held (−1%) | $2.62 | $30K | -22.1% | — |
| Nov 12SEC | John J. BonifaceChief Scientific Officer | Sell | 7,767151,726 held (−5%) | $2.62 | $20K | -22.1% | — |
| Nov 12SEC | Paul KearneyChief Data Officer | Sell | 7,073168,596 held (−4%) | $2.62 | $19K | -22.1% | — |
| Nov 12SEC | Benjamin JacksonGeneral Counsel | Sell | 7,059119,758 held (−6%) | $2.62 | $18K | -22.1% | — |
| Nov 12SEC | Robert Gardner HarrisonChief Information Officer | Sell | 6,52889,404 held (−7%) | $2.62 | $17K | -22.1% | — |
| Nov 12SEC | Austin AertsCFO | Sell | 6,351278,319 held (−2%) | $2.62 | $17K | -22.1% | — |
| Nov 6SEC | Mansoor Raza MirzaDirector | Sell | 22158,032 held (−0%) | $3.04 | $672 | -32.9% | — |
| Nov 4SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00095,932 held (−2%) | $3.07 | $6K | -33.6% | — |
| Oct 8SEC | Robert Gardner HarrisonChief Information Officer | Sell Plan | 2,00097,932 held (−2%) | $3.18 | $6K | -35.8% | — |
| Oct 6SEC | Mansoor Raza MirzaDirector | Sell | 22758,253 held (−0%) | $3.16 | $717 | -35.4% | — |
Insiders at SERA PROGNOSTICS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Zhenya LindgardtCEO | — | $291K | Sep 11, 2026 | — |
| Paul KearneyChief Data Officer | — | $131K | Mar 12, 2026 | — |
| Austin AertsCFO | — | $66K | Jun 15, 2026 | — |
| Robert Gardner HarrisonChief Information Officer | — | $62K | Mar 12, 2026 | — |
| Benjamin JacksonGeneral Counsel | — | $38K | Sep 11, 2026 | — |
| John J. BonifaceChief Scientific Officer | — | $34K | Mar 12, 2026 | — |
| Dyaarl Lee Anderson Jr.Chief Commercial Officer | — | $13K | Sep 11, 2026 | — |
| Sandra Aj LawrenceDirector | — | $11K | Jun 9, 2026 | — |
| Mansoor Raza MirzaDirector | — | $2K | Dec 5, 2025 | — |
| Tiffany Eul Davis InglisChief Medical Officer | — | $2K | Sep 11, 2026 | — |
SERA stock: common questions
Are SERA PROGNOSTICS, INC. insiders buying SERA stock?
In the past 12 months, 0 insiders reported open-market purchases of SERA worth $0.
Are SERA PROGNOSTICS, INC. insiders selling SERA stock?
10 insiders reported sales worth $643K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is SERA's 52-week range?
Over the past year SERA has traded between $1.59 and $3.75. It last closed at $2.04 on Oct 9, 2026.